Genito-Urinary Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Genito-Urinary Drugs Market covers analysis By Product (Urologicals, Hormonal Therapy, Gynecological, Anti-infectives, Others); Indication (Prostate Cancer, Ovarian Cancer, Bladder Cancer, Cervical Cancer, Renal Cancer, Erectile Dysfunction, Urinary Tract Infections, Sexually Transmitted Diseases, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00021893
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Genito-Urinary Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

MARKET INTRODUCTION

Genitourinary disorders are the conditions that deals with genital and urinary system. Genitourinary drugs are used to treat disorders related to kidney, ureters, bladder and urethra. The diagnosis of the genitourinary system involves the entire urinary tract and male genital tract. Genitourinary infections may be communicable and caused by organisms such as bacteria or yeast. It is estimated that one in five women will suffer from urinary tract infection in her lifetime. Antibiotics are the first line of treatment for urinary tract infections. Genitourinary cancers are cancer in the urinary system e.g. prostate cancer, ovarian cancer, bladder cancer and cervical cancer. Growing incidence of genitourinary disorder will drive genitourinary drug market.

MARKET DYNAMICS

Genito-urinary drugs market is driving due to factors such as growing prevalence of genitourinary disorders and increasing number of pipeline drugs. However, the influx of a wide range of counterfeit and generics launched by big pharmaceutical companies as well as small and medium-sized drug manufacturers are likely to create a negative impact on the growth of this market.

MARKET SCOPE

The Genito-urinary drugs market analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Genito-urinary drugs Market with detailed market segmentation by product and indication. The Genito-urinary drugs Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Genito-urinary drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Genito-urinary drugs market is segmented based on product and indication. Based on product, market is segmented as Urological, Hormonal Therapy, Gynecological, Anti-infectives, Others. Based on indication, market is segmented as Prostate Cancer, Ovarian Cancer, Bladder Cancer, Cervical Cancer, Renal Cancer, Erectile Dysfunction, Urinary Tract Infections, Sexually Transmitted Diseases, Others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Genito-urinary drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Genito-urinary drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Genito-urinary drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Genito-urinary drugs market in these regions.

Genito-Urinary Drugs Market Report Analysis

Genito-Urinary Drugs Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Melinta Therapeutics Inc.
  • Cipla USA Inc.
  • Allergan PLC
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Astellas Pharma
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd.
  • AstraZeneca

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

By Product
  • Urologicals
  • Hormonal Therapy
  • Gynecological
  • Anti-infectives
  • Others
By Indication
  • Prostate Cancer
  • Ovarian Cancer
  • Bladder Cancer
  • Cervical Cancer
  • Renal Cancer
  • Erectile Dysfunction
  • Urinary Tract Infections
  • Sexually Transmitted Diseases
  • Others
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS


The report covers key developments in the Genito-urinary drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as Application and End user launches, Application and End user approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Genito-urinary drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for Genito-urinary drugs in the global market. Below mentioned is the list of few companies engaged in the Genito-urinary drugs Market.

The report also includes the profiles of key players in Genito-urinary drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Melinta Therapeutics Inc.
  •   Cipla USA Inc.
  •   Allergan PLC
  •   Merck & Co. Inc.
  •   Pfizer Inc.
  •   Astellas Pharma
  •   GlaxoSmithKline plc
  •   Teva Pharmaceutical Industries Ltd.
  •   AstraZeneca
  •   Bristol-Myers Squibb Company
  •   Novartis AG
  •   Eli Lilly and Company
  •   Advanz Pharmaceutical

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Genito-Urinary Drugs Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Urologicals
  • Hormonal Therapy
  • Gynecological
  • Anti-infectives
  • Others
By Indication
  • Prostate Cancer
  • Ovarian Cancer
  • Bladder Cancer
  • Cervical Cancer
  • Renal Cancer
  • Erectile Dysfunction
  • Urinary Tract Infections
  • Sexually Transmitted Diseases
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Melinta Therapeutics Inc.
  • Cipla USA Inc.
  • Allergan PLC
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Astellas Pharma
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd.
  • AstraZeneca
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Melinta Therapeutics Inc.
    2. Cipla USA Inc.
    3. Allergan PLC
    4. Merck & Co. Inc.
    5. Pfizer Inc.
    6. Astellas Pharma
    7. GlaxoSmithKline plc
    8. Teva Pharmaceutical Industries Ltd.
    9. AstraZeneca
    10. Bristol-Myers Squibb Company
    11. Novartis AG
    12. Eli Lilly and Company
    13. Advanz Pharmaceutical

    Trends and growth analysis reports related to Pharmaceuticals : READ MORE..